Paper Details

  1. Home
  2. Paper Details

Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients.

Author: LevineB S, SongM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the pharmacokinetics and efficacy of pulse oral and intravenous (i.v.) calcitriol in hemodialysis patients with secondary hyperparathyroidism. The study found that intravenous calcitriol achieved higher peak levels but did not have a clinically significant difference in efficacy compared to oral calcitriol. The study suggests that both intravenous and oral calcitriol are effective for suppressing parathyroid hormone (PTH) secretion in hemodialysis patients.
Paper Details　
Original Abstract of the Article :
Because intravenous (iv) calcitriol has greater bioavailability than oral calcitriol, it may be more efficacious in suppressing parathyroid hormone (PTH) secretion. In this study, the pharmacokinetics and efficacy of pulse oral and i.v. calcitriol were compared. Patients were randomized to receive 2...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1681/ASN.V73488

データ提供：米国国立医学図書館（NLM）

Pulse Oral Versus Intravenous Calcitriol: A Comparative Study in Hemodialysis Patients

This study navigates the complex realm of nephrology, specifically addressing the treatment of secondary hyperparathyroidism in hemodialysis patients. The researchers investigated the pharmacokinetics and efficacy of two different routes of calcitriol administration, pulse oral and intravenous (IV), in patients with secondary hyperparathyroidism. The study aimed to compare the effectiveness of both routes in suppressing parathyroid hormone (PTH) secretion, a critical hormone in calcium regulation. The findings revealed that both pulse oral and IV calcitriol demonstrated comparable efficacy in suppressing PTH levels and achieving similar clinical outcomes.

Calcitriol Delivery: A Choice for Hemodialysis Patients

This study provides valuable insights for clinicians treating hemodialysis patients with secondary hyperparathyroidism. The researchers demonstrated that both pulse oral and IV calcitriol are effective options for managing PTH levels and achieving clinical improvement. This finding offers flexibility in treatment approaches, allowing clinicians to choose the route of administration that best suits the individual patient's needs and preferences.

Managing Hyperparathyroidism: A Collaborative Approach

This study emphasizes the importance of a collaborative approach in managing hyperparathyroidism in hemodialysis patients. Working closely with a nephrologist and other healthcare professionals can help patients achieve optimal health outcomes. The choice between oral and IV calcitriol should be made in consultation with a medical professional, considering factors such as individual patient needs, treatment preferences, and potential side effects.

Dr. Camel's Conclusion

This research is like a refreshing oasis in the desert of kidney health. It shows that there are multiple paths to achieving optimal outcomes in managing hyperparathyroidism in hemodialysis patients. Just as a camel can navigate the desert by seeking out water sources, patients with hyperparathyroidism can work with their healthcare team to find the right treatment approach for their individual needs.
Date :
  1. Date Completed 1996-09-11
  2. Date Revised 2021-05-18
Further Info :

Pubmed ID

8704116

DOI: Digital Object Identifier

10.1681/ASN.V73488

Related Literature

Article Analysis
・Effects of calcitriol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.